Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze BMRN stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate BMRN investment potential.

What is BMRN stock price today?

Get real-time BMRN stock price, historical data, and price charts on Financhill. Track BMRN performance with our advanced analysis tools.

Is BMRN a good investment?

Evaluate BMRN investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy BMRN stock?

To buy BMRN stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of BMRN?

View detailed market capitalization data and company valuation metrics for BMRN on our comprehensive analysis page.

What is the P/E ratio of BMRN?

Use our fundamental analysis tools to view BMRN P/E ratio and compare valuation metrics with industry peers.

What are BMRN earnings?

View BMRN earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

BioMarin Pharmaceutical, Inc. 10K Form

Buy

BMRN
BioMarin Pharmaceutical, Inc.

Last Price:

$61.19

Seasonality Move:

5.52%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-04-26	10Q	BMRN/BioMarin Pharmaceutical, Inc. Quarterly
2024-02-26	10K	BMRN/BioMarin Pharmaceutical, Inc. Annual
2023-11-02	10Q	BMRN/BioMarin Pharmaceutical, Inc. Quarterly
2023-08-02	10Q	BMRN/BioMarin Pharmaceutical, Inc. Quarterly
2023-04-28	10Q	BMRN/BioMarin Pharmaceutical, Inc. Quarterly
2023-02-27	10K	BMRN/BioMarin Pharmaceutical, Inc. Annual

Receive BMRN News And Ratings

See the #1 stock for the next 7 days that we like better than BMRN

BMRN Financial Statistics

Sales & Book Value

Annual Sales:	$2.8B
Cash Flow:	$334.9M
Price / Cash Flow:	14.48
Annual Sales:	$31.53
Price / Book:	1.94

Profitability

EPS (TTM):	2.66890
Net Income (TTM):	$520.4M
Gross Margin:	$2.2B
Return on Equity:	8.99%
Return on Assets:	7.22%

BioMarin Pharmaceutical, Inc. Earnings Forecast

Key BioMarin Pharmaceutical, Inc. Financial Ratios

The Gross Profit Margin over the past 27 years for BMRN is 78.04%.
The Selling, General & Administrative Expenses for BMRN have been equal to 35.54% of Gross Profit Margin.
The Research & Development expenses have been 26.32% of Revenue.
The Interest Expense is 2.97% of Operating Income.
The Net Earning history of BMRN is 15.03% of Total Revenues.
Per Share Earnings over the last 27 years have been positive in 15 years.

BioMarin Pharmaceutical, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	BMRN
CUSIP:	09061G
Website:	biomarin.com

Debt

Debt-to-Equity Ratio:	0.1
Current Ratio:	4.83
Quick Ratio:	2.84

Price-to-Earnings

Trailing P/E Ratio:	27.7
Forward P/E Ratio:	11.63

BMRN Technical Analysis vs Fundamental Analysis

Buy

BioMarin Pharmaceutical, Inc. (BMRN) is a Buy

Is BioMarin Pharmaceutical, Inc. a Buy or a Sell?

BioMarin Pharmaceutical, Inc. stock is rated a Buy

The current BioMarin Pharmaceutical, Inc. [BMRN] share price is $61.15. The Score for BMRN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.